000 02386 a2200589 4500
005 20250516081248.0
264 0 _c20120604
008 201206s 0 0 eng d
022 _a1550-6606
024 7 _a10.4049/jimmunol.1103693
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBeurskens, Frank J
245 0 0 _aExhaustion of cytotoxic effector systems may limit monoclonal antibody-based immunotherapy in cancer patients.
_h[electronic resource]
260 _bJournal of immunology (Baltimore, Md. : 1950)
_cApr 2012
300 _a3532-41 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAlemtuzumab
650 0 4 _aAntibodies, Monoclonal
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Humanized
_xadministration & dosage
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadministration & dosage
650 0 4 _aAntibody-Dependent Cell Cytotoxicity
650 0 4 _aAntigens, CD20
_ximmunology
650 0 4 _aAntigens, Neoplasm
_ximmunology
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aB-Lymphocyte Subsets
_xdrug effects
650 0 4 _aCell Line, Tumor
_xdrug effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aComplement Activation
650 0 4 _aComplement C3b
_xanalysis
650 0 4 _aComplement C4b
_xanalysis
650 0 4 _aComplement System Proteins
_ximmunology
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aCytotoxicity, Immunologic
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdrug therapy
650 0 4 _aLymphocyte Count
650 0 4 _aOpsonin Proteins
_ximmunology
650 0 4 _aRituximab
650 0 4 _aVidarabine
_xadministration & dosage
700 1 _aLindorfer, Margaret A
700 1 _aFarooqui, Mohammed
700 1 _aBeum, Paul V
700 1 _aEngelberts, Patrick
700 1 _aMackus, Wendy J M
700 1 _aParren, Paul W H I
700 1 _aWiestner, Adrian
700 1 _aTaylor, Ronald P
773 0 _tJournal of immunology (Baltimore, Md. : 1950)
_gvol. 188
_gno. 7
_gp. 3532-41
856 4 0 _uhttps://doi.org/10.4049/jimmunol.1103693
_zAvailable from publisher's website
999 _c21577182
_d21577182